vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Quipt Home Medical Corp. (QIPT). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $47.7M, roughly 1.0× IRONWOOD PHARMACEUTICALS INC). Quipt Home Medical Corp. runs the higher net margin — -2.1% vs -4.8%, a 2.6% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $6.9M).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
IRWD vs QIPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $49.0M |
| Net Profit | $-2.3M | $-1.1M |
| Gross Margin | — | 53.5% |
| Operating Margin | 14.3% | 2.1% |
| Net Margin | -4.8% | -2.1% |
| Revenue YoY | -47.3% | 32.3% |
| Net Profit YoY | -200.9% | 2.9% |
| EPS (diluted) | $0.01 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $49.0M | ||
| Q3 25 | $122.1M | $39.8M | ||
| Q2 25 | $85.2M | $35.1M | ||
| Q1 25 | $41.1M | $33.3M | ||
| Q4 24 | $90.5M | $37.1M | ||
| Q3 24 | $91.6M | — | ||
| Q2 24 | $94.4M | — | ||
| Q1 24 | $74.9M | — |
| Q4 25 | $-2.3M | $-1.1M | ||
| Q3 25 | $40.1M | $-3.5M | ||
| Q2 25 | $23.6M | $-3.0M | ||
| Q1 25 | $-37.4M | $-3.0M | ||
| Q4 24 | $2.3M | $-1.1M | ||
| Q3 24 | $3.6M | — | ||
| Q2 24 | $-860.0K | — | ||
| Q1 24 | $-4.2M | — |
| Q4 25 | — | 53.5% | ||
| Q3 25 | — | 48.7% | ||
| Q2 25 | — | 57.6% | ||
| Q1 25 | — | 54.6% | ||
| Q4 24 | — | 52.1% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 14.3% | 2.1% | ||
| Q3 25 | 61.8% | -3.6% | ||
| Q2 25 | 53.2% | -5.2% | ||
| Q1 25 | -70.7% | -3.0% | ||
| Q4 24 | 34.8% | 1.2% | ||
| Q3 24 | 28.0% | — | ||
| Q2 24 | 26.5% | — | ||
| Q1 24 | 14.7% | — |
| Q4 25 | -4.8% | -2.1% | ||
| Q3 25 | 32.8% | -8.9% | ||
| Q2 25 | 27.7% | -8.6% | ||
| Q1 25 | -90.9% | -9.1% | ||
| Q4 24 | 2.5% | -2.9% | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | $0.01 | $-0.02 | ||
| Q3 25 | $0.23 | $-0.07 | ||
| Q2 25 | $0.14 | $-0.07 | ||
| Q1 25 | $-0.23 | $-0.07 | ||
| Q4 24 | $0.03 | $-0.03 | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.01 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $10.5M |
| Total DebtLower is stronger | — | $84.0M |
| Stockholders' EquityBook value | $-261.8M | $113.0M |
| Total Assets | $396.9M | $280.7M |
| Debt / EquityLower = less leverage | — | 0.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $10.5M | ||
| Q3 25 | $140.4M | $12.9M | ||
| Q2 25 | $92.9M | $11.3M | ||
| Q1 25 | $108.5M | $17.1M | ||
| Q4 24 | $88.6M | $15.5M | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | $84.0M | ||
| Q3 25 | $199.5M | $87.6M | ||
| Q2 25 | $199.3M | $66.0M | ||
| Q1 25 | $199.2M | $71.5M | ||
| Q4 24 | $199.0M | $70.6M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $113.0M | ||
| Q3 25 | $-264.2M | $112.1M | ||
| Q2 25 | $-308.2M | $102.5M | ||
| Q1 25 | $-334.1M | $103.6M | ||
| Q4 24 | $-301.3M | $106.3M | ||
| Q3 24 | $-311.3M | — | ||
| Q2 24 | $-321.7M | — | ||
| Q1 24 | $-330.5M | — |
| Q4 25 | $396.9M | $280.7M | ||
| Q3 25 | $396.1M | $283.3M | ||
| Q2 25 | $342.9M | $236.1M | ||
| Q1 25 | $327.2M | $244.6M | ||
| Q4 24 | $350.9M | $242.8M | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $395.6M | — | ||
| Q1 24 | $438.8M | — |
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $8.9M |
| Free Cash FlowOCF − Capex | $74.6M | $6.9M |
| FCF MarginFCF / Revenue | 156.3% | 14.0% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $26.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $8.9M | ||
| Q3 25 | $47.6M | $9.8M | ||
| Q2 25 | $-15.1M | $9.7M | ||
| Q1 25 | $20.0M | $8.9M | ||
| Q4 24 | $15.2M | $9.3M | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.5M | — | ||
| Q1 24 | $45.0M | — |
| Q4 25 | $74.6M | $6.9M | ||
| Q3 25 | $47.6M | $8.0M | ||
| Q2 25 | $-15.1M | $4.4M | ||
| Q1 25 | $19.9M | $7.3M | ||
| Q4 24 | — | $5.6M | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | 14.0% | ||
| Q3 25 | 39.0% | 20.0% | ||
| Q2 25 | -17.7% | 12.6% | ||
| Q1 25 | 48.4% | 22.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | 4.2% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 14.9% | ||
| Q1 25 | 0.1% | 4.8% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
